Terms: = Liver cancer AND TOP1, RP3-511B24_2, 7150, ENSG00000198900, TOPI, P11387
85026 results:
1. Use of Natural Language Processing to Infer Sites of Metastatic Disease From Radiology Reports at Scale.
Tay SB; Low GH; Wong GJE; Tey HJ; Leong FL; Li C; Chua MLK; Tan DSW; Thng CH; Tan IBH; Tan RSYC
JCO Clin Cancer Inform; 2024 May; 8():e2300122. PubMed ID: 38788166
[TBL] [Abstract] [Full Text] [Related]
2. The efficacy and safety of apatinib combined with S-1 for advanced gastric cancer: A systematic review and meta-analysis.
Chen X; Wan L; He Y; Zhang Q; Zheng X
Medicine (Baltimore); 2024 May; 103(21):e38272. PubMed ID: 38787998
[TBL] [Abstract] [Full Text] [Related]
3. Value of Sonazoid-enhanced ultrasonography in characterizing indeterminate focal liver lesions on gadoxetic acid-enhanced liver MRI in patients without risk factors for hepatocellular carcinoma.
Ban JY; Kang TW; Jeong WK; Lee MW; Park B; Song KD
PLoS One; 2024; 19(5):e0304352. PubMed ID: 38787832
[TBL] [Abstract] [Full Text] [Related]
4. Based on Gadolinium Ethoxybenzyl DTPA-Enhanced MRI: Diagnostic Performance of the Category-Modified LR-5 Criteria in Patients At Risk for Hepatocellular Carcinoma.
Li S; Deng K; Qiu J; Wang P; Yin D; Xie Y; Yu Y
Technol Cancer Res Treat; 2024; 23():15330338241256859. PubMed ID: 38780516
[No Abstract] [Full Text] [Related]
5. Dosimetric Effect of Target Position Accuracy on Single-Isocenter Multiple liver Metastases SBRT.
Zhang Y; Niu S; Yuan J; Wang X; Gong C; Tang C
Technol Cancer Res Treat; 2024; 23():15330338241257422. PubMed ID: 38780512
[No Abstract] [Full Text] [Related]
6. Unveiling the role of the KLF4/Lnc18q22.2/ULBP3 axis in the tumorigenesis and immune escape of hepatocellular carcinoma under hypoxic condition.
Wei L; He P; Tan Z; Zhao L; Lin C; Wei Z
J Cell Mol Med; 2024 May; 28(10):e18411. PubMed ID: 38780505
[TBL] [Abstract] [Full Text] [Related]
7. The health care experience of adults with metabolic dysfunction-associated steatohepatitis and influence of PNPLA3: A qualitative study.
Stine JG; Medic N; Pettersson B; Venerus M; Blau JE
Hepatol Commun; 2024 Jun; 8(6):. PubMed ID: 38780312
[TBL] [Abstract] [Full Text] [Related]
8. PNPLA3 risk allele is associated with risk of hepatocellular carcinoma but not decompensation in compensated cirrhosis.
Urias E; Tedesco NR; Burkholder DA; Moran IJ; Miller MJ; Jasty VSJ; Patil S; Zoellner S; Wijarnpreecha K; Chen VL
Hepatol Commun; 2024 Jun; 8(6):. PubMed ID: 38780253
[TBL] [Abstract] [Full Text] [Related]
9. ULK1 Mediated Autophagy-Promoting Effects of Rutin-Loaded Chitosan Nanoparticles Contribute to the Activation of NF-κB Signaling Besides Inhibiting EMT in Hep3B Hepatoma Cells.
Wu P; Wang X; Yin M; Zhu W; Chen Z; Zhang Y; Jiang Z; Shi L; Zhu Q
Int J Nanomedicine; 2024; 19():4465-4493. PubMed ID: 38779103
[TBL] [Abstract] [Full Text] [Related]
10. Drug screening on digital microfluidics for cancer precision medicine.
Zhai J; Liu Y; Ji W; Huang X; Wang P; Li Y; Li H; Wong AH; Zhou X; Chen P; Wang L; Yang N; Chen C; Chen H; Mak PI; Deng CX; Martins R; Yang M; Ho TY; Yi S; Yao H; Jia Y
Nat Commun; 2024 May; 15(1):4363. PubMed ID: 38778087
[TBL] [Abstract] [Full Text] [Related]
11. Higher habitual intakes of flavonoids and flavonoid-rich foods are associated with a lower incidence of type 2 diabetes in the UK Biobank cohort.
Thompson AS; Jennings A; Bondonno NP; Tresserra-Rimbau A; Parmenter BH; Hill C; Perez-Cornago A; Kühn T; Cassidy A
Nutr Diabetes; 2024 May; 14(1):32. PubMed ID: 38778045
[TBL] [Abstract] [Full Text] [Related]
12. Dietary inflammatory index after liver transplantation: Associated effects and long-term outcomes.
Hott CA; Santos BC; Hebert JR; Zhao L; Wirth MD; Vilela EG; Anastácio LR
Clin Nutr ESPEN; 2024 Jun; 61():349-355. PubMed ID: 38777454
[TBL] [Abstract] [Full Text] [Related]
13. Vitamin D and viral infections: Infectious diseases, autoimmune diseases, and cancers.
Grant WB
Adv Food Nutr Res; 2024; 109():271-314. PubMed ID: 38777416
[TBL] [Abstract] [Full Text] [Related]
14. Impact of an Automated Population-Level Cirrhosis Screening Program Using Common Pathology Tests on Rates of Cirrhosis Diagnosis and Linkage to Specialist Care (CAPRISE): Protocol for a Pilot Prospective Single-Arm Intervention Study.
Flores JE; Trambas C; Jovanovic N; Thompson AJ; Howell J
JMIR Res Protoc; 2024 May; 13():e56607. PubMed ID: 38776541
[TBL] [Abstract] [Full Text] [Related]
15. Ultrasound-guided percutaneous biopsy for focal liver lesions: Adverse events and diagnostic yield in a single-centre analysis.
Pöschel T; Blank V; Schlosser T; Lingscheidt T; Böhlig A; Wiegand J; Karlas T
PLoS One; 2024; 19(5):e0304026. PubMed ID: 38776359
[TBL] [Abstract] [Full Text] [Related]
16. Blocking the angiopoietin-2-dependent integrin β-1 signaling axis abrogates small cell lung cancer invasion and metastasis.
Meder L; Orschel CI; Otto CJ; Koker M; Brägelmann J; Ercanoglu MS; Dähling S; Compes A; Selenz C; Nill M; Dietlein F; Florin A; Eich ML; Borchmann S; Odenthal M; Blazquez R; Hilberg F; Klein F; Hallek M; Büttner R; Reinhardt HC; Ullrich RT
JCI Insight; 2024 May; 9(10):. PubMed ID: 38775153
[TBL] [Abstract] [Full Text] [Related]
17. Women Are Also Disadvantaged in Accessing Transplant Outside the United States: Analysis of the Spanish liver Transplantation Registry.
Tejedor M; Neria F; De La Rosa G; Almohalla Álvarez C; Padilla M; Boscà Robledo A; Fundora Suárez Y; Sánchez-Bueno F; Gómez-Bravo MA; Berenguer M
Transpl Int; 2024; 37():12732. PubMed ID: 38773987
[TBL] [Abstract] [Full Text] [Related]
18. The role of adjuvant transcatheter arterial chemoembolization following repeated curative resection/ablation for hepatocellular carcinoma with early recurrence: a propensity score matching analysis.
Huang K; Qian T; Chen W; Lao M; Li H; Lin WC; Chen BW; Bai X; Gao S; Ma T; Liang T
BMC Cancer; 2024 May; 24(1):620. PubMed ID: 38773564
[TBL] [Abstract] [Full Text] [Related]
19. Predictive nomograms based on gamma-glutamyl transpeptidase to prealbumin ratio for prognosis of hepatocellular carcinoma patients without microvascular invasion.
Ma M; Xie K; Jin T; Xu F
BMC Cancer; 2024 May; 24(1):617. PubMed ID: 38773511
[TBL] [Abstract] [Full Text] [Related]
20. Broadening Eligibility Criteria and Diversity among Patients for cancer Clinical Trials.
Kaur M; Frahm F; Lu Y; Ascha MS; Guadamuz JS; Dotan E; Gottesman AS; Leybovich BC; Sondhi A; Zhao Y; Meropol NJ; Royce TJ
NEJM Evid; 2024 Apr; 3(4):EVIDoa2300236. PubMed ID: 38771994
[TBL] [Abstract] [Full Text] [Related]
[Next]